2019
DOI: 10.1002/pbc.27901
|View full text |Cite
|
Sign up to set email alerts
|

Congenital malformation syndromes associated with peripheral neuroblastic tumors: A systematic review

Abstract: Malformation syndromes with predisposition to peripheral neuroblastic tumors (pNT), including neuroblastoma, ganglioneuroblastoma, and ganglioneuroma, may provide clues to critical mutations influencing pNT development. Our objective was to identify and characterize features of pNT associated with specific malformation syndromes. A systematic review of the literature was performed using MEDLINE, Scopus, and Web of Science. We identified 154 of 1014 papers that met eligibility, comprising 207 cases. The patient… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 98 publications
0
1
0
1
Order By: Relevance
“…From 2010 to 2019, we collected clinical samples from NB (n = 9, retroperitoneal origin, mainly younger than 5 years old) ( 26 ), ganglioneuroblastoma (GNB, n = 2), olfactory neuroblastoma (ONB, n = 7), and retinoblastoma (RB, n = 6) patients in 1 st Affiliated Hospital of University of Science and Technology of Chima (USTC) and 2 nd Affiliated Hospital of Dalian Medical University (DMU) for IHC analysis ( Figures 1A–D ) to know the expression pattern of related proteins. Peripheral neuroblastic tumors are further classified based on their morphological features into NB, GNB, and ganglioneuroma (GN), known as the International Neuroblastoma Pathology Classification (INPC; Shimada system), which are relevant biologically and prognostically ( 27 ). Compared with ONB ( Figure 1C ) and RB ( Figure 1D ), the IHC staining of retroperitoneum-initiated NB showed significant higher (P < 0.05) expression of AR, SCAP, and especially the drug targets, HMGCR and CYP17A1 ( Figure 1E ).…”
Section: Resultsmentioning
confidence: 99%
“…From 2010 to 2019, we collected clinical samples from NB (n = 9, retroperitoneal origin, mainly younger than 5 years old) ( 26 ), ganglioneuroblastoma (GNB, n = 2), olfactory neuroblastoma (ONB, n = 7), and retinoblastoma (RB, n = 6) patients in 1 st Affiliated Hospital of University of Science and Technology of Chima (USTC) and 2 nd Affiliated Hospital of Dalian Medical University (DMU) for IHC analysis ( Figures 1A–D ) to know the expression pattern of related proteins. Peripheral neuroblastic tumors are further classified based on their morphological features into NB, GNB, and ganglioneuroma (GN), known as the International Neuroblastoma Pathology Classification (INPC; Shimada system), which are relevant biologically and prognostically ( 27 ). Compared with ONB ( Figure 1C ) and RB ( Figure 1D ), the IHC staining of retroperitoneum-initiated NB showed significant higher (P < 0.05) expression of AR, SCAP, and especially the drug targets, HMGCR and CYP17A1 ( Figure 1E ).…”
Section: Resultsmentioning
confidence: 99%
“…Механизмы развития ганглионевромы до конца не выяснены. Ученые склоняются к значительной роли в данном вопросе генетического фактора [5,6].…”
unclassified